These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29673103)

  • 1. Allopurinol and endothelial function: A systematic review with meta-analysis of randomized controlled trials.
    Alem MM
    Cardiovasc Ther; 2018 Aug; 36(4):e12432. PubMed ID: 29673103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol therapy improves vascular endothelial function in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials.
    Xin W; Mi S; Lin Z
    Cardiovasc Ther; 2016 Dec; 34(6):441-449. PubMed ID: 27542348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.
    George J; Struthers AD
    Vasc Health Risk Manag; 2009; 5(1):265-72. PubMed ID: 19436671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Xanthine Oxidase Inhibitors in Patients with History of Stroke: A Systematic Review.
    Britnell SR; Chillari KA; Brown JN
    Curr Vasc Pharmacol; 2018; 16(6):583-588. PubMed ID: 28933307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials.
    Bredemeier M; Lopes LM; Eisenreich MA; Hickmann S; Bongiorno GK; d'Avila R; Morsch ALB; da Silva Stein F; Campos GGD
    BMC Cardiovasc Disord; 2018 Feb; 18(1):24. PubMed ID: 29415653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopurinol improves endothelial dysfunction in chronic heart failure.
    Farquharson CA; Butler R; Hill A; Belch JJ; Struthers AD
    Circulation; 2002 Jul; 106(2):221-6. PubMed ID: 12105162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis.
    Higgins P; Dawson J; Lees KR; McArthur K; Quinn TJ; Walters MR
    Cardiovasc Ther; 2012 Aug; 30(4):217-26. PubMed ID: 22099531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.
    Sakuma M; Toyoda S; Arikawa T; Koyabu Y; Kato T; Adachi T; Suwa H; Narita JI; Anraku K; Ishimura K; Yamauchi F; Sato Y; Inoue T;
    Clin Exp Nephrol; 2018 Dec; 22(6):1379-1386. PubMed ID: 29916098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopurinol and endothelial function in heart failure: future or fantasy?
    Landmesser U; Drexler H
    Circulation; 2002 Jul; 106(2):173-5. PubMed ID: 12105153
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients.
    Dogan A; Yarlioglues M; Kaya MG; Karadag Z; Dogan S; Ardic I; Dogdu O; Kilinc Y; Zencir C; Akpek M; Ozdogru I; Oguzhan A; Kalay N
    Blood Press; 2011 Jun; 20(3):182-7. PubMed ID: 21133824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
    Doehner W; Schoene N; Rauchhaus M; Leyva-Leon F; Pavitt DV; Reaveley DA; Schuler G; Coats AJ; Anker SD; Hambrecht R
    Circulation; 2002 Jun; 105(22):2619-24. PubMed ID: 12045167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopurinol as a therapeutic option in cardiovascular disease.
    Okafor ON; Farrington K; Gorog DA
    Pharmacol Ther; 2017 Apr; 172():139-150. PubMed ID: 27916655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting.
    Singh TP; Skalina T; Nour D; Murali A; Morrison S; Moxon JV; Golledge J
    BMC Cardiovasc Disord; 2018 Jul; 18(1):143. PubMed ID: 29996770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia - A systematic review and meta-analysis.
    Liu CW; Chang WC; Lee CC; Shau WY; Hsu FS; Wang ML; Chen TC; Lo C; Hwang JJ
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1011-1022. PubMed ID: 31378626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthine Oxidase Inhibitors for Improving Renal Function in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis.
    Pisano A; Cernaro V; Gembillo G; D'Arrigo G; Buemi M; Bolignano D
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29088122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers.
    Guthikonda S; Sinkey C; Barenz T; Haynes WG
    Circulation; 2003 Jan; 107(3):416-21. PubMed ID: 12551865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopurinol use is associated with greater functional gains in older rehabilitation patients.
    Beveridge LA; Ramage L; McMurdo ME; George J; Witham MD
    Age Ageing; 2013 May; 42(3):400-4. PubMed ID: 23542724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthine Oxidase Inhibitor Allopurinol Prevents Oxidative Stress-Mediated Atrial Remodeling in Alloxan-Induced Diabetes Mellitus Rabbits.
    Yang Y; Zhao J; Qiu J; Li J; Liang X; Zhang Z; Zhang X; Fu H; Korantzopoulos P; Letsas KP; Tse G; Li G; Liu T
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase inhibitors the unappreciated treatment for heart failure.
    Ellestad MH
    Cardiovasc Hematol Disord Drug Targets; 2007 Dec; 7(4):291-4. PubMed ID: 18220728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk.
    Mercuro G; Vitale C; Cerquetani E; Zoncu S; Deidda M; Fini M; Rosano GM
    Am J Cardiol; 2004 Oct; 94(7):932-5. PubMed ID: 15464681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.